ACCL News Alert Accelrys Inc (ACCL) 12.51 12/25/2014 14:08:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Accelrys Inc (ACCL) 12.51 $ACCL

Accelrys Up 33.6% Since SmarTrend Uptrend Call (ACCL)
Comtex SmarTrend(R) - Mon Dec 22, 5:10PM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 15 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)

Accelrys Shares Up 33.6% Since SmarTrend's Buy Recommendation (ACCL)
Comtex SmarTrend(R) - Mon Dec 15, 11:06AM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 15 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)

Shares of ACCL Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 01, 9:20AM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 15 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)

33.6% Return Seen to Date on SmarTrend Accelrys Call (ACCL)
Comtex SmarTrend(R) - Fri Nov 21, 4:48PM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 14 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)

Accelrys Has Returned 33.6% Since SmarTrend Recommendation (ACCL)
Comtex SmarTrend(R) - Thu Oct 23, 5:02PM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 13 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)

Uptrend Call Working As Accelrys Stock Rises 33.6% (ACCL)
Comtex SmarTrend(R) - Wed Sep 17, 11:09AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 12 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)

Global Bioinformatics Market Outlook 2019
M2 - Wed Sep 17, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xtd5rk/global) has announced the addition of the "Global Bioinformatics Market Outlook 2019" report to their offering. The global bioinformatics market reached the mark of around US$ 3.7 Billion in 2013 with the anticipation of its growth at a CAGR of around 19% during 2015-2019 The report is an outcome of an in-depth research and comprehensive analysis of global developments and opportunities listed in the section of the bioinformatics trends. The bioinformatics market essentially is divided into 3 sections for a categorical study of the industry viz. by segment, by application and by region. By segment, the bioinformatics market is divided into data analysis and software, tools and database services, and IT Infrastructure. Accordingly, the report provides a comprehensive analysis of each of these segments coupled with the information on key software and databases popular in the industry. In the application area of the bioinformatics industry, the report covers various aspects of the global bioinformatics market, giving detailed analysis of its various applications, including genomics, proteomics, transcriptomics, cheminformatics, metabolomics and molecular phylogenetics, covering the sizes of the bioinformatics market for each of these application areas till 2019. The report also offers a geographical picture of the bioinformatics sector in four regions viz. North America, Europe, Asia-Pacific and Latin America. Additionally, through country level analysis, the report portrays the bioinformatics market in major countries like US, UK, South Korea, India etc., to understand their individual market growth and future directions. A competitive analysis in the report has been done with an assortment of all the major bioinformatics players that have been active in the research and development of bioinformatics products and services. It encloses the overview, key financials and strategic initiatives by the players. In a nutshell, the research provides all the prerequisite information for intending clients looking out to venture into this industry and facilitates them to devise strategies, while going for an investment/partnership in the global bioinformatics market. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Key Industry Trends and Drivers 4. Bioinformatics Market Outlook to 2019 5. Country Level Analysis 6. Commercialized Products and Services 7. Key Players - Biodiscovery, Inc. - Geneva Bioinformatics (Genebio) SA - Kinexus Bioinformatics Corporation - Accelrys, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - CLC Bio A/S - Genologics Life Sciences Software, Inc - ID Business Solutions Ltd - Illumina Inc. - Life Technologies Corporation - NonLinear Dynamics Ltd. For more information visit http://www.researchandmarkets.com/research/xtd5rk/global
A: 41.13 (-0.24), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05), ACCL: 12.51 (+0.03)

Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART D: ANNEXURE 1. RESEARCH METHOLOGY 2. FEEDBACK Companies Mentioned: - 4-Antibody AG - Abbott Laboratories - Accelrys, Inc. - Affymetrix Inc. - Agilent Technologies Inc. - Asahi Kasei Pharma Corporation - Astrazeneca Plc - Aviva Biosciences Corp. - Bayer Healthcare AG - BD Biosciences - Beckman Coulter Inc. - Biacore International AB - Bioanalytical Systems, Inc. - Bio-Rad Laboratories, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Caliper Life Sciences, Inc. - Caprion Proteomics, Inc. - Celera Corporation - Celgene Corporation - Charles River Laboratories International, Inc. - Compugen Ltd. - Decode Genetics, Inc. - EMD Millipore Corporation - Evotec AG - GE Healthcare Ltd. - Genedata AG - Hitgen Ltd - Hudson Robotics, Inc. - Illumina Inc. - Incyte Corporation - Isis Pharmaceuticals, Inc. - Kyowa Hakko Kirin Co., Ltd. - Luminex Corporation - Maxcyte, Inc - Merck & Co., Inc. - Millennium Pharmaceuticals, Inc. - Molecular Devices, LLC - Molecular Discovery Ltd. - Molecular Discovery Systems Pty., Ltd. - New England Biolabs, Inc. - Novartis AG - Osiris Therapeutics Inc. - Perkinelmer, Inc. - Promega Corporation - Qiagen N.V. - Quantum Pharmaceuticals - Roche Holding AG - Shimadzu Corporation - Sigma-Aldrich Corporation - Sri Biosciences - Tecan Group Ltd. - The National Center for Drug Screening - Thermo Fisher Scientific Inc. - Viva Biotech Ltd - Waters Corp. For more information visit http://www.researchandmarkets.com/research/dt..._discovery
A: 41.13 (-0.24), OSIR: 14.87 (+0.13), ILMN: 186.22 (+2.72), LMNX: 18.60 (+0.37), AFFX: 9.80 (+0.05), QGEN: 23.20 (+0.09), BCOR: 13.90 (-0.03), ACCL: 12.51 (+0.03), ABT: 45.70 (-0.02), INCY: 71.57 (+1.99), BMY: 59.15 (-0.01), WAT: 114.54 (+0.21), ISIS: 59.49 (+1.88), SIAL: 137.16 (-0.01), BASI: 2.09 (-0.11), MRK: 57.46 (+0.25), CGEN: 8.58 (-0.17), CRL: 63.59 (+0.33), CELGZ: 3.34 (-0.01), NVS: 93.91 (+0.66)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 47

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
PayPal Adds a Risk Hand to Its Board at a Crucial Turn

Updated Category News Views 91

A Boardroom Hire With Some Actual Weight PayPal did not go hunting for another decorative résumé. Brian J. Lee, set to join the board on November 30, 2026, spent decades inside Goldman Sachs, including a stint as chief risk officer from 2019 through January 2025. For a payments company trying to sharpen its financial-services identity, that is a serious piece of...

Continue Reading
Babe Ruth Lots Lead Morphy's $2 Million Collectibles Auction

Updated Category News Views 61

Ruth still pulls money like few names ever will, and Morphy's November 10-12 auction made that plain without any circus tricks. Three lots tied to the Yankees legend produced $136,500 within a Toys, Sports & General Collectibles sale that topped $2 million. That is not some vague nostalgia story. Buyers put real dollars behind a 1932 U.S. Caramel card, a 1933 Goudey card,...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 62

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 133

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 113

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 77

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading

Top 5 Most Recently Viewed Articles

Sarepta Therapeutics Faces Class Action Lawsuit: Key Facts

Updated Category News Views 222

Understanding the Recent Class Action Against Sarepta Therapeutics The law firm of Kessler Topaz Meltzer & Check, LLP has announced an important development for investors in Sarepta Therapeutics, Inc. (NASDAQ: SRPT). A securities class action lawsuit has been filed in the Southern District of New York, which impacts those who purchased or otherwise acquired Sarepta's...

Continue Reading
Honoring Dr. Marvin Boomer Jr. and Advocating for Justice

Updated Category News Views 459

A Community's Tribute to Dr. Marvin Boomer Jr. Today we unite not just in sorrow but in a fierce dedication to remember Dr. Marvin Boomer Jr. His life, marked by brilliance and inspiration, serves as a beacon for many. As we reflect on his contributions, we recognize the larger struggles that affect our community. The Impact of Dr. Boomer's Legacy Dr. Marvin Boomer Jr....

Continue Reading
Key Economic Events and Insights from Kashkari's Speech

Updated Category News Views 154

Anticipating Economic Insights from Kashkari's Address As financial markets gear up for another significant day, numerous crucial economic events are set to occur. Traders are especially keen on the insights that FOMC Member Neel Kashkari may share regarding the Federal Reserve's stance on monetary policy. His speech is expected to potentially guide market reactions and...

Continue Reading
Discover Compelling Dividend Stocks for Investors

Updated Category News Views 126

Exploring Attractive Dividend Stocks The stock market has recently reached several new all-time highs, influenced by a variety of economic factors. While this upward trend has benefited many stocks, it has also limited the number of valuable bargains for investors. However, some companies still stand out as exceptional investment opportunities. Currently, three notable...

Continue Reading
New Housing Initiatives in Canada to Combat Housing Shortage

Updated Category News Views 264

Boosting Housing Availability Across Canada The governments are coming together to tackle the pressing issue of affordable housing in Canada. Their concerted efforts have culminated in a substantial funding package aimed at enhancing the housing landscape. Recently, over $44 million has been dedicated towards constructing more than 280 new homes, further expanding the...

Continue Reading